|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/39 | (2006.01) |
| A61K 9/127 | (2006.01) |
| (11) | Number of the document | 2611461 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11758014.2 |
| Date of filing the European patent application | 2011-08-31 | |
| (97) | Date of publication of the European application | 2013-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-09 |
| (46) | Date of publication of the claims translation | 2022-08-10 |
| (86) | Number | PCT/US2011/050095 |
| Date | 2011-08-31 |
| (87) | Number | WO 2012/031043 |
| Date | 2012-03-08 |
| (30) | Number | Date | Country code |
| 378826 P | 2010-08-31 | US |
| (72) |
GEALL, Andrew , US
VERMA, Ayush , US
|
| (73) |
GlaxoSmithKline Biologicals SA ,
Rue de l'Institut 89, 1330 Rixensart,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pegilintos liposomos, skirtos imunogeną koduojančios RNR tiekimui |
| PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 15 | 289.00 EUR |
| 2026-08-31 |